Home Tags Aim

Tag: aim

Latest article

Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial

Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...